Preterm Infant Growth
Growth of Preterm Infants Consuming Formula
1 other identifier
interventional
150
1 country
9
Brief Summary
The purpose of this study is to assess growth of preterm infants fed a test formula compared to a standard formula up to the first 4 months of corrected gestational age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2010
Longer than P75 for not_applicable
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2010
CompletedFirst Posted
Study publicly available on registry
July 15, 2010
CompletedStudy Start
First participant enrolled
September 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedNovember 4, 2014
November 1, 2014
3.1 years
July 13, 2010
November 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Growth
weight gain assessed monthly
4 months
Secondary Outcomes (2)
growth, tolerance, morbidity
6 months
Total body bone mineral content and density and body composition, protein status, and metabolic markers
corrected term and 4 months
Study Arms (2)
Control
ACTIVE COMPARATORcommercially available formula
Test
EXPERIMENTALtest formula
Interventions
test infant formula fed to infants until 6 months corrected gestational age
commercially available infant formula
Eligibility Criteria
You may qualify if:
- Born AGA
- Exclusively formula-fed
- weeks GA at birth
- Intact GI tract, tolerating full oral feeds
- Expected to be discharged from the hospital within a minimum of 24 hours, maximum of 5 days
You may not qualify if:
- Severe respiratory disease defined as needing mechanical ventilation at discharge
- Any significant systemic diseases that could affect growth. This includes cardiac, neurologic, or GI conditions.
- Major congenital malformation, history of GI surgery, severe postnatal complications
- Daily or routine diuretic use at time of discharge
- Receiving more than 10% of daily kcals from food additives such as thickeners
- Currently participating or having participated in another conflicting clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Children's Hospital & Research Center
Oakland, California, United States
Advocate Lutheran Children's Hospital
Park Ridge, Illinois, United States
University of Iowa
Iowa City, Iowa, 52241, United States
Center for Human Nutrition
Omaha, Nebraska, 68105, United States
Midatlantic Neonatology Associates, Inc
Morristown, New Jersey, 07962, United States
Children's Hospital Medical Center of Akron
Akron, Ohio, 44308, United States
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
University of Utah, Dept of Pediatrics
Salt Lake City, Utah, 84108, United States
VCU Children's Medical Center
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ekhard Ziegler, MD
University of Iowa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2010
First Posted
July 15, 2010
Study Start
September 1, 2010
Primary Completion
October 1, 2013
Study Completion
September 1, 2014
Last Updated
November 4, 2014
Record last verified: 2014-11